Hydrogen gas treatment for newborn brain injury
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This trial tests whether giving hydrogen gas through a breathing tube can help protect the brain of newborns who had a difficult birth and may have brain damage. It may help reduce the risk of long-term disability.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be born at 36 weeks of pregnancy or later
- Your baby must have had a difficult birth event, such as an emergency C-section, low Apgar score, or breathing problems that needed resuscitation
- Your baby must have signs of brain injury (moderate or severe encephalopathy) within the first 2 hours after birth
- Your baby must be on a breathing machine (ventilator) at the time of the study
- Your baby must not have serious heart defects, genetic conditions, or major birth defects that need surgery
- Your baby must not be on a special type of high-frequency ventilator (like Drager Babylog)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for newborn babies who had an oxygen shortage around birth and now have severe brain injury. It aims to test approaches that may help improve outcomes after this kind of early-life brain damage.
This study looks at a blood test that might help check brain injury in newborns who had a lack of oxygen at birth. The test could give doctors more information to help care for your baby.
This trial studies whether RLS-0071 is safe and can help some newborns with moderate or severe hypoxic-ischemic encephalopathy (HIE), a brain injury caused by low oxygen around birth. Babies in the study also receive standard whole-body cooling (therapeutic hypothermia), and the researchers will watch for side effects and early signs of benefit.
This study uses EEG (a test that records brain activity) to help doctors quickly identify brain injury in newborns who had a difficult birth. If successful, it could lead to earlier treatment and better outcomes.
This early study tests whether giving melatonin to newborns with hypoxic-ischemic encephalopathy (brain injury from not enough oxygen around birth) can help protect the brain while they are cooled (therapeutic hypothermia). It may be most relevant if your baby shows early brain-injury signs and meets specific blood test and birth-history timing criteria.
This trial tests whether giving both magnesium sulfate and melatonin to newborns with brain injury from lack of oxygen works better than magnesium sulfate alone. The goal is to see if the combination improves recovery and reduces long-term disability.
Hear when a new HIE trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.